InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire09-03 20:00

MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28^th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).

A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at https://investors.inspiremd.com.

To request a meeting or for more details about the conferences, please reach out to your institutional contact.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2664779728?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664779728","market":"us","top_or_hot":-1,"title":"InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference","media":"GlobeNewswire","content":"<html><body><p>MIAMI, Sept.  03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard<sup>®</sup> Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28<sup>th</sup> Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).</p> <p>A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at <u>https://investors.inspiremd.com</u>.</p> <p>To request a meeting or for more details about the conferences, please reach out to your institutional contact.</p> <p><strong>About InspireMD, Inc.</strong><br/>InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.</p> <p><strong>Investor Contacts:</strong><br/>Jeff Warren<br/>LifeSci Advisors<br/>jwarren@lifesciadvisors.com<br/>investor-relations@inspiremd.com</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/YjlhZmI0ZDktYThlZC00NzQwLWIxM2ItMWM5MjhhODU0YjM0LTExOTc4MTYtMjAyNi0wOS0wMy1lbg==/tiny/InspireMD-Inc-.png\"/></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2026-09-03 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>MIAMI, Sept.  03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard<sup>®</sup> Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28<sup>th</sup> Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).</p> <p>A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at <u>https://investors.inspiremd.com</u>.</p> <p>To request a meeting or for more details about the conferences, please reach out to your institutional contact.</p> <p><strong>About InspireMD, Inc.</strong><br/>InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.</p> <p><strong>Investor Contacts:</strong><br/>Jeff Warren<br/>LifeSci Advisors<br/>jwarren@lifesciadvisors.com<br/>investor-relations@inspiremd.com</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/YjlhZmI0ZDktYThlZC00NzQwLWIxM2ItMWM5MjhhODU0YjM0LTExOTc4MTYtMjAyNi0wOS0wMy1lbg==/tiny/InspireMD-Inc-.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355854/0/en/inspiremd-to-participate-in-upcoming-h-c-wainwright-28th-annual-global-investment-conference.html","article_id":"2664779728","we_media_id":"1016364462","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664779728","pubTimestamp":1788436800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"GlobeNewswire","introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"summary":"MIAMI, Sept.  03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announc","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","EMLP":"第一信托北美能源基础设施基金","BK4144":"石油与天然气的储存和运输","AMLP":"Alerian MLP ETF","AMZA":"InfraCap MLP ETF","MDST":"Westwood Salient Enhanced Midstream Income ETF","BK4590":"PTP","EIPI":"FT Energy Income Partners Enhanced Income Etf","BK4585":"ETF&股票定投概念","BK4198":"医疗保健用品","EIPX":"FT ENERGY INCOME PARTNERS STRATEGY ETF","USAI":"Pacer American Energy Independence ETF","NSPR":"InspireMD Inc.","TPZ":"Tortoise Electrification Infrastructure ETF","BK4561":"索罗斯持仓","MLPA":"Global X MLP ETF","ET":"Energy Transfer LP","BK4588":"碎股","UMI":"USCF Midstream Energy Income Fund","ENFR":"Alerian Energy Infrastructure ET","TNGY":"Tortoise Energy Fund"},"translate_title":"激励MD参加即将到来的H.C。温赖特第28届全球投资年会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMLP":0.6,"EIPX":0.6,"AMZA":0.6,"USAI":0.6,"AMLP":0.6,"ET":1,"TPZ":0.6,"TNGY":0.6,"UMI":0.6,"NSPR":1.5,"ENFR":0.6,"MDST":0.6,"EIPI":0.6,"MLPA":0.6},"content_text":"MIAMI, Sept.  03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET). A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at https://investors.inspiremd.com. To request a meeting or for more details about the conferences, please reach out to your institutional contact. About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com. Investor Contacts:Jeff WarrenLifeSci Advisorsjwarren@lifesciadvisors.cominvestor-relations@inspiremd.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2664779728","isCrawlerRequest":true}